{
  "id": "5a96f40cfcd1d6a10c00002b",
  "type": "summary",
  "question": "What is calciphylaxis",
  "ideal_answer": "Calcific uraemic arteriolopathy also known as calciphylaxis is an unusual and potentially fatal condition characterised by small-vessel calcification and ischaemic skin necrosis.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26908770",
    "http://www.ncbi.nlm.nih.gov/pubmed/9426423",
    "http://www.ncbi.nlm.nih.gov/pubmed/20019019",
    "http://www.ncbi.nlm.nih.gov/pubmed/18045036",
    "http://www.ncbi.nlm.nih.gov/pubmed/23663061",
    "http://www.ncbi.nlm.nih.gov/pubmed/21410615",
    "http://www.ncbi.nlm.nih.gov/pubmed/18417747",
    "http://www.ncbi.nlm.nih.gov/pubmed/26779700",
    "http://www.ncbi.nlm.nih.gov/pubmed/27321367",
    "http://www.ncbi.nlm.nih.gov/pubmed/27935078",
    "http://www.ncbi.nlm.nih.gov/pubmed/22892472",
    "http://www.ncbi.nlm.nih.gov/pubmed/26871829",
    "http://www.ncbi.nlm.nih.gov/pubmed/27068711",
    "http://www.ncbi.nlm.nih.gov/pubmed/28220742",
    "http://www.ncbi.nlm.nih.gov/pubmed/24096524",
    "http://www.ncbi.nlm.nih.gov/pubmed/19317304",
    "http://www.ncbi.nlm.nih.gov/pubmed/25847841",
    "http://www.ncbi.nlm.nih.gov/pubmed/12434450",
    "http://www.ncbi.nlm.nih.gov/pubmed/16368166",
    "http://www.ncbi.nlm.nih.gov/pubmed/11012592",
    "http://www.ncbi.nlm.nih.gov/pubmed/16108246",
    "http://www.ncbi.nlm.nih.gov/pubmed/23430392",
    "http://www.ncbi.nlm.nih.gov/pubmed/10764004",
    "http://www.ncbi.nlm.nih.gov/pubmed/11273880"
  ],
  "snippets": [
    {
      "text": "Calcific uraemic arteriolopathy (calciphylaxis) is an unusual and potentially fatal condition characterised by small-vessel calcification and ischaemic skin necrosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28220742",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Renal failure-associated calciphylaxis, also termed calcific uremic arteriolopathy (CUA), is a life-threatening condition usually observed in patients with end-stage renal disease on chronic dialysis or after renal transplantation",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27935078",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calcific uraemic arteriolopathy (CUA, calciphylaxis) is a rare disease predominantly in dialysis patients and associated with high mortality. Painful skin ulcerations and calcification of cutaneous arterioles characterize calciphylaxis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26908770",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "<b>WHAT IS KNOWN AND OBJECTIVE</b>: Calciphylaxis is a rare and potentially life-threatening cause of skin necrosis and is poorly recognized by clinicians in non-uraemic patients.<br><b>CASE DESCRIPTION</b>: We report five cases of warfarin-induced calciphylaxis in patients with normal renal function.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27321367",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND AND OBJECTIVES: Calciphylaxis, or calcific uremic arteriolopathy, is a well-described entity in end-stage kidney disease and renal transplant patients; however, little systematic information is available on calciphylaxis from nonuremic causes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18417747",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "WHAT IS KNOWN AND OBJECTIVE Calciphylaxis is a rare and potentially life-threatening cause of skin necrosis and is poorly recognized by clinicians in non-uraemic patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27321367",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE Calciphylaxis, a rare disorder typically affecting renal failure patients, results in vascular calcification with subsequent skin necrosis, gangrene, and often death from sepsis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10764004",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a metastatic calcification-induced vasculopathy that results in the occlusion of small blood vessels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23663061",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a small vessel vasculopathy, characterized by medial wall calcification that develops in a few patients with chronic renal failure.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26871829",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND Calciphylaxis is a syndrome consisting of vascular calcification, thrombosis, and skin necrosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27068711",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is characterized by calcification in the medium and small vessel arterioles and can be a life-threatening complication often associated with chronic kidney disease (CKD).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26779700",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is characterized by painful, violaceous, mottled skin lesions (livedo reticularis) that may progress to tissue necrosis, nonhealing ulcers, gangrene, and potentially amputation, sepsis, or death.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9426423",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a relatively rare disease, observed mainly in patients on dialysis, associated with high mortality rates, and characterized by painful skin ulceration.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23430392",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a rare condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification. It is characterized by acute calcium deposition in the medial layer of small and intermediate dermal vasculature that can lead to epidermal ischemia, ulceration, and necrosis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16108246",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a rare condition characterized by medial calcification of small- and medium-sized vessels that subsequently leads to ischemic necrosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892472",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a disease in which metastatic calcification affects small- and medium-sized vessels resulting in significant dermatologic manifestations.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21410615",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a severe complication of chronic renal failure, confined almost exclusively to patients on dialysis therapy. Histological characteristics of calciphylaxis include small-vessel calcifications of skin, subcutaneous tissue, and visceral organs. These vascular changes promote tissue ischemia that often results in tissue necrosis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11273880",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calcific uraemic arteriolopathy, also named calciphylaxis, is a rare but serious disorder characterized by medial mural calcification of small vessel leading to tissue ischaemia. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18045036",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a rare complication that occurs in 1% of patients with end-stage renal disease (ESRD) each year. Extensive microvascular calcification and occlusion/thrombosis lead to violaceous skin lesions, which progress to nonhealing ulcers with secondary infection, often leading to sepsis and death. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19317304",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a rare, usually fatal vasculopathic disorder characterized by cutaneous ischemia and necrosis due to calcification of arterioles",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20019019",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a rare and potentially fatal complication of end stage renal disease (ESRD) and secondary hyperparathyroidism associated with abnormal calcium metabolism. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12434450",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis causes calcification, thrombosis, cutaneous ischemia, and necrosis in the skin and subcutaneous tissue",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24096524",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis is a rare phenomenon of medium- and small-vessel calcifications leading to cutaneous necrosis mimicking vasculitis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16368166",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Calciphylaxis combines features of vascular thrombotic occlusion and endoluminal calcification. I",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25847841",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Calciphylaxis refers to a syndrome of calcium deposition in the small and intermediate dermal vasculature which can lead to epidermal ischaemia, ulceration and necrosis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11012592",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "https://meshb.nlm.nih.gov/record/ui?ui=D002115",
    "http://www.disease-ontology.org/api/metadata/DOID:4734"
  ]
}